Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$11.28 - $25.46 $57,528 - $129,846
-5,100 Reduced 10.39%
44,000 $1.09 Million
Q3 2023

Nov 08, 2023

BUY
$16.34 - $24.66 $70,262 - $106,038
4,300 Added 9.6%
49,100 $816,000
Q2 2023

Aug 09, 2023

SELL
$16.06 - $21.61 $281,050 - $378,175
-17,500 Reduced 28.09%
44,800 $837,000
Q1 2023

May 10, 2023

SELL
$17.19 - $30.8 $118,611 - $212,520
-6,900 Reduced 9.97%
62,300 $1.14 Million
Q4 2022

Feb 08, 2023

BUY
$16.28 - $24.6 $211,640 - $319,800
13,000 Added 23.13%
69,200 $1.37 Million
Q3 2022

Nov 09, 2022

BUY
$17.96 - $30.46 $10,776 - $18,276
600 Added 1.08%
56,200 $1.35 Million
Q2 2022

Aug 09, 2022

BUY
$10.26 - $23.59 $104,652 - $240,618
10,200 Added 22.47%
55,600 $1.02 Million
Q1 2022

May 09, 2022

BUY
$17.02 - $40.22 $54,464 - $128,704
3,200 Added 7.58%
45,400 $998,000
Q4 2021

Feb 08, 2022

BUY
$29.5 - $39.5 $26,550 - $35,550
900 Added 2.18%
42,200 $1.55 Million
Q3 2021

Nov 08, 2021

SELL
$29.86 - $39.47 $53,748 - $71,046
-1,800 Reduced 4.18%
41,300 $1.28 Million
Q2 2021

Aug 06, 2021

BUY
$17.99 - $40.02 $127,728 - $284,142
7,100 Added 19.72%
43,100 $1.37 Million
Q4 2020

Feb 05, 2021

BUY
$15.89 - $40.87 $572,040 - $1.47 Million
36,000 New
36,000 $711,000

Others Institutions Holding RAPT

About RAPT Therapeutics, Inc.


  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $26.1M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.